vs

Side-by-side financial comparison of HAIN CELESTIAL GROUP INC (HAIN) and Sotera Health Co (SHC). Click either name above to swap in a different company.

HAIN CELESTIAL GROUP INC is the larger business by last-quarter revenue ($384.1M vs $303.4M, roughly 1.3× Sotera Health Co). Sotera Health Co runs the higher net margin — 11.5% vs -30.2%, a 41.7% gap on every dollar of revenue. On growth, Sotera Health Co posted the faster year-over-year revenue change (4.6% vs -6.7%). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs -6.4%).

The Hain Celestial Group, Inc. is an international food and personal-care company based in the United States. Its products include natural foods and organic personal-care items. Founded in 1993 as Hain Food Group, it changed its name to Hain Celestial Group after merging with Celestial Seasonings in 2000. It is publicly traded on the NASDAQ with brands that include Ella's Kitchen, Frank Cooper's, and Linda McCartney Foods.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

HAIN vs SHC — Head-to-Head

Bigger by revenue
HAIN
HAIN
1.3× larger
HAIN
$384.1M
$303.4M
SHC
Growing faster (revenue YoY)
SHC
SHC
+11.2% gap
SHC
4.6%
-6.7%
HAIN
Higher net margin
SHC
SHC
41.7% more per $
SHC
11.5%
-30.2%
HAIN
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
-6.4%
HAIN

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
HAIN
HAIN
SHC
SHC
Revenue
$384.1M
$303.4M
Net Profit
$-116.0M
$34.8M
Gross Margin
19.4%
54.7%
Operating Margin
-25.7%
23.2%
Net Margin
-30.2%
11.5%
Revenue YoY
-6.7%
4.6%
Net Profit YoY
-11.6%
182.8%
EPS (diluted)
$-1.28
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HAIN
HAIN
SHC
SHC
Q4 25
$384.1M
$303.4M
Q3 25
$367.9M
$311.3M
Q2 25
$363.3M
$294.3M
Q1 25
$390.4M
$254.5M
Q4 24
$411.5M
$290.2M
Q3 24
$394.6M
$285.5M
Q2 24
$418.8M
$276.6M
Q1 24
$438.4M
$248.2M
Net Profit
HAIN
HAIN
SHC
SHC
Q4 25
$-116.0M
$34.8M
Q3 25
$-20.6M
$48.4M
Q2 25
$-272.6M
$8.0M
Q1 25
$-134.6M
$-13.3M
Q4 24
$-104.0M
$12.3M
Q3 24
$-19.7M
$17.0M
Q2 24
$-2.9M
$8.8M
Q1 24
$-48.2M
$6.3M
Gross Margin
HAIN
HAIN
SHC
SHC
Q4 25
19.4%
54.7%
Q3 25
18.5%
57.0%
Q2 25
20.5%
56.6%
Q1 25
21.7%
53.2%
Q4 24
22.7%
56.6%
Q3 24
20.7%
55.4%
Q2 24
23.4%
55.2%
Q1 24
22.1%
51.2%
Operating Margin
HAIN
HAIN
SHC
SHC
Q4 25
-25.7%
23.2%
Q3 25
-1.9%
23.4%
Q2 25
-69.3%
6.4%
Q1 25
-31.0%
-5.8%
Q4 24
-22.3%
30.0%
Q3 24
0.8%
28.2%
Q2 24
2.9%
27.8%
Q1 24
-6.4%
21.4%
Net Margin
HAIN
HAIN
SHC
SHC
Q4 25
-30.2%
11.5%
Q3 25
-5.6%
15.5%
Q2 25
-75.0%
2.7%
Q1 25
-34.5%
-5.2%
Q4 24
-25.3%
4.2%
Q3 24
-5.0%
6.0%
Q2 24
-0.7%
3.2%
Q1 24
-11.0%
2.5%
EPS (diluted)
HAIN
HAIN
SHC
SHC
Q4 25
$-1.28
$0.12
Q3 25
$-0.23
$0.17
Q2 25
$-3.03
$0.03
Q1 25
$-1.49
$-0.05
Q4 24
$-1.15
$0.05
Q3 24
$-0.22
$0.06
Q2 24
$-0.03
$0.03
Q1 24
$-0.54
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HAIN
HAIN
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$68.0M
$344.6M
Total DebtLower is stronger
$388.0K
$2.1B
Stockholders' EquityBook value
$330.2M
$606.0M
Total Assets
$1.5B
$3.3B
Debt / EquityLower = less leverage
0.00×
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HAIN
HAIN
SHC
SHC
Q4 25
$68.0M
$344.6M
Q3 25
$47.9M
$299.2M
Q2 25
$54.4M
$332.4M
Q1 25
$44.4M
$304.4M
Q4 24
$56.2M
$277.2M
Q3 24
$56.9M
$306.7M
Q2 24
$54.3M
$246.1M
Q1 24
$49.5M
$261.1M
Total Debt
HAIN
HAIN
SHC
SHC
Q4 25
$388.0K
$2.1B
Q3 25
$708.6M
$2.1B
Q2 25
$697.2M
$2.2B
Q1 25
$701.4M
$2.2B
Q4 24
$721.1M
$2.2B
Q3 24
$732.8M
$2.2B
Q2 24
$736.5M
$2.2B
Q1 24
$769.9M
$2.2B
Stockholders' Equity
HAIN
HAIN
SHC
SHC
Q4 25
$330.2M
$606.0M
Q3 25
$445.0M
$550.5M
Q2 25
$475.0M
$511.3M
Q1 25
$696.7M
$414.1M
Q4 24
$804.7M
$404.9M
Q3 24
$963.7M
$470.2M
Q2 24
$942.9M
$422.8M
Q1 24
$944.5M
$429.4M
Total Assets
HAIN
HAIN
SHC
SHC
Q4 25
$1.5B
$3.3B
Q3 25
$1.6B
$3.2B
Q2 25
$1.6B
$3.2B
Q1 25
$1.8B
$3.1B
Q4 24
$2.0B
$3.1B
Q3 24
$2.1B
$3.1B
Q2 24
$2.1B
$3.1B
Q1 24
$2.1B
$3.1B
Debt / Equity
HAIN
HAIN
SHC
SHC
Q4 25
0.00×
3.53×
Q3 25
1.59×
3.89×
Q2 25
1.47×
4.34×
Q1 25
1.01×
5.36×
Q4 24
0.90×
5.49×
Q3 24
0.76×
4.73×
Q2 24
0.78×
5.26×
Q1 24
0.82×
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HAIN
HAIN
SHC
SHC
Operating Cash FlowLast quarter
$37.0M
$103.1M
Free Cash FlowOCF − Capex
$52.4M
FCF MarginFCF / Revenue
17.3%
Capex IntensityCapex / Revenue
16.7%
Cash ConversionOCF / Net Profit
2.96×
TTM Free Cash FlowTrailing 4 quarters
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HAIN
HAIN
SHC
SHC
Q4 25
$37.0M
$103.1M
Q3 25
$-8.5M
$71.2M
Q2 25
$-2.6M
$57.4M
Q1 25
$4.6M
$55.5M
Q4 24
$30.9M
$55.7M
Q3 24
$-10.8M
$97.5M
Q2 24
$39.4M
$61.3M
Q1 24
$42.3M
$9.7M
Free Cash Flow
HAIN
HAIN
SHC
SHC
Q4 25
$52.4M
Q3 25
$35.0M
Q2 25
$26.2M
Q1 25
$35.6M
Q4 24
$-10.2M
Q3 24
$61.1M
Q2 24
$19.4M
Q1 24
$-25.2M
FCF Margin
HAIN
HAIN
SHC
SHC
Q4 25
17.3%
Q3 25
11.2%
Q2 25
8.9%
Q1 25
14.0%
Q4 24
-3.5%
Q3 24
21.4%
Q2 24
7.0%
Q1 24
-10.2%
Capex Intensity
HAIN
HAIN
SHC
SHC
Q4 25
16.7%
Q3 25
11.6%
Q2 25
10.6%
Q1 25
7.8%
Q4 24
22.7%
Q3 24
12.7%
Q2 24
15.2%
Q1 24
14.1%
Cash Conversion
HAIN
HAIN
SHC
SHC
Q4 25
2.96×
Q3 25
1.47×
Q2 25
7.21×
Q1 25
Q4 24
4.52×
Q3 24
5.73×
Q2 24
7.00×
Q1 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HAIN
HAIN

Other$175.5M46%
Snacks$71.9M19%
Baby Kids$53.6M14%
Western Europe$50.5M13%
CA$20.9M5%
Personal Care$11.9M3%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons